FierceBiotech 2026年4月24日 After Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy?
FierceBiotech 2026年4月22日 Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
FierceBiotech 2026年4月7日 Lilly pays AC Immune $12.5M to expand Alzheimer’s collab as asset draws closer to clinic
FierceBiotech 2026年3月31日 Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play
FierceBiotech 2026年3月23日 Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear
FierceBiotech 2026年3月19日 Lilly's obesity discovery partner Fauna sees weight loss potential in hibernating mammals
FierceBiotech 2026年3月19日 Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trial
FierceBiotech 2026年2月9日 Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
FierceBiotech 2026年2月4日 Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout
FierceBiotech 2026年1月29日 Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
FierceBiotech 2026年1月28日 Lilly pens $1.1B pact with German biotech to work on gene editing med for hearing loss
FierceBiotech 2026年1月12日 JPM26, Day 1: Stock market titans Lilly, Nvidia expand team-up with AI co-innovation lab
FierceBiotech 2026年1月12日 Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment
FierceBiotech 2026年1月8日 Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M
FierceBiotech 2025年12月11日 Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some
FierceBiotech 2025年12月8日 With weight loss windfall, Lilly looks to become ‘backbone’ of global innovation: exec